Description
*Transferred from sars-cov-2-variants/lineage-proposals#2353
Defining mutations:
LP.8.1>C21627A (S:T22N)
GISAID Query: C4999T, C21627A, C22120A, C23039G,
Earliest seq: 2024-10-21 (Taiwan, China-EPI_ISL_19522303)
Most recent seq: 2025-01-03 (NY, US-EPI_ISL_19666138)
Countries detected: US 14, China 6, Japan 3, Spain 2, France 1, Canada 1, Thailand 1(detected from Japan Intl Airport)
S:T22N is popular and convergent in almost with added NTD Glycan. the original LP.8.1 lineage gets S:Q493E while without S:T22N, maybe the added mutation can further increase the growth rate.
Genomes:
EPI_ISL_19522303, EPI_ISL_19574561, EPI_ISL_19601561, EPI_ISL_19602029, EPI_ISL_19615862, EPI_ISL_19623944, EPI_ISL_19629064, EPI_ISL_19629074, EPI_ISL_19639556, EPI_ISL_19640047, EPI_ISL_19640369, EPI_ISL_19643740, EPI_ISL_19643743, EPI_ISL_19643748, EPI_ISL_19643761, EPI_ISL_19650427, EPI_ISL_19651624, EPI_ISL_19651637, EPI_ISL_19656578-19656579, EPI_ISL_19657167, EPI_ISL_19658511-19658512, EPI_ISL_19658583, EPI_ISL_19660540, EPI_ISL_19663074, EPI_ISL_19664117, EPI_ISL_19666138